• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从 Aphanothece sacrum 中提取的新型多糖 sacran 对体内 2,4,6-三硝基氯苯诱导的过敏性皮炎的抗炎作用。

Anti-inflammatory effects of sacran, a novel polysaccharide from Aphanothece sacrum, on 2,4,6-trinitrochlorobenzene-induced allergic dermatitis in vivo.

机构信息

Department of Environmental Medicine, Kochi Medical School, Kochi University, Nankoku, Kochi, Japan.

出版信息

Ann Allergy Asthma Immunol. 2012 Feb;108(2):117-22. doi: 10.1016/j.anai.2011.10.013. Epub 2011 Nov 29.

DOI:10.1016/j.anai.2011.10.013
PMID:22289731
Abstract

BACKGROUND

Sacran is a newly discovered sulfated polysaccharide extracted from an algae, Aphanothece sacrum, grown in a river of the Kyushu region in Japan.

OBJECTIVE

To evaluate sacran's inhibitory effect in 2,4,6-trinitrochlorobenzene (TNCB)-induced allergic dermatitis in NC/Nga mice.

METHODS

Sacran was extracted by acid and alkaline treatment of A sacrum cyanobacterial biomaterials. To sensitize mice, 150 μL of 5% TNCB was applied epicutaneously on the abdomen of each mouse on day 1 and challenged with 15 μL of 1% TNCB applied on the ear skin of mice on day 8 and then every other day to induce skin lesions. Serum levels of inflammatory markers were measured and histopathologic examination of ear skin specimens performed. On the other hand, sacran's transepidermal water loss was evaluated in 11 volunteer women with dry skin.

RESULTS

Epicutaneous application of sacran in mice has significantly inhibited the development of allergic dermatitis skin lesions and reduced the number of scratching behavior episodes (P < .01). In addition, sacran efficiently inhibited IgE (P < .001), tumor necrosis factor α (P = .02), interleukin 4, interleukin 5, and interferon γ (P < .01; vs buffer in the TNCB group) production and eosinophilic infiltration in the chemical allergen-exposed ear skin. In addition, sacran-treated body regions of human volunteers with dry skin significantly reduced transepidermal water loss levels compared with exogenous hyaluronic acid (P < .01), which is known to improve skin moisture and exert skin barrier repair activity.

CONCLUSIONS

This study suggests that sacran exerts anti-inflammatory effects by improving skin barrier function and reducing T(H)2 cytokine production.

摘要

背景

沙聚糖是一种从日本九州河流中生长的蓝藻 Aphanothece sacrum 中提取的新型硫酸化多糖。

目的

评价沙聚糖对 2,4,6-三硝基氯苯(TNCB)诱导的 NC/Nga 小鼠过敏性皮炎的抑制作用。

方法

通过对 A 蓝藻生物材料进行酸碱性处理提取沙聚糖。致敏小鼠时,将 5% TNCB 溶液 150 μL 涂于每只小鼠腹部的表皮上,第 1 天;第 8 天,将 1% TNCB 溶液 15 μL 涂于小鼠耳部皮肤进行挑战,然后每隔一天对小鼠进行一次皮肤损伤诱导。测量血清炎症标志物水平,并对耳部皮肤标本进行组织病理学检查。另一方面,在 11 名患有干燥皮肤的志愿者女性中评估沙聚糖的经皮水分丢失。

结果

沙聚糖经皮应用于小鼠可显著抑制过敏性皮炎皮损的发展,并减少搔抓行为发作次数(P <.01)。此外,沙聚糖还能有效抑制 IgE(P <.001)、肿瘤坏死因子-α(P =.02)、白细胞介素 4、白细胞介素 5 和干扰素 γ(P <.01;与 TNCB 组中的缓冲液相比)的产生,以及嗜酸性粒细胞在化学变应原暴露的耳部皮肤中的浸润。此外,与已知能改善皮肤水分并发挥皮肤屏障修复作用的外源性透明质酸相比,沙聚糖处理的干燥皮肤志愿者身体部位的经皮水分丢失水平显著降低(P <.01)。

结论

本研究表明,沙聚糖通过改善皮肤屏障功能和减少 TH2 细胞因子的产生发挥抗炎作用。

相似文献

1
Anti-inflammatory effects of sacran, a novel polysaccharide from Aphanothece sacrum, on 2,4,6-trinitrochlorobenzene-induced allergic dermatitis in vivo.从 Aphanothece sacrum 中提取的新型多糖 sacran 对体内 2,4,6-三硝基氯苯诱导的过敏性皮炎的抗炎作用。
Ann Allergy Asthma Immunol. 2012 Feb;108(2):117-22. doi: 10.1016/j.anai.2011.10.013. Epub 2011 Nov 29.
2
GATA-3 regulates contact hyperresponsiveness in a murine model of allergic dermatitis.GATA-3 调控变应性性皮炎小鼠模型的接触超敏反应。
Immunobiology. 2012 Apr;217(4):446-54. doi: 10.1016/j.imbio.2011.10.009. Epub 2011 Nov 6.
3
Effects of TNCB sensitization in DS-Nh mice, serving as a model of atopic dermatitis, in comparison with NC/Nga mice.与NC/Nga小鼠相比,作为特应性皮炎模型的DS-Nh小鼠中三硝基氯苯致敏的影响。
Int Arch Allergy Immunol. 2005 Feb;136(2):173-80. doi: 10.1159/000083326. Epub 2005 Jan 12.
4
Anti-allergic effects of Vernonia amygdalina leaf extracts in hapten-induced atopic dermatitis-like disease in mice.山芝麻叶提取物对变应原诱导的小鼠特应性皮炎样疾病的抗过敏作用。
Allergol Int. 2012 Dec;61(4):597-607. doi: 10.2332/allergolint.11-OA-0393. Epub 2012 Aug 25.
5
Effect of Lactobacillus acidophilus strain L-55 on the development of atopic dermatitis-like skin lesions in NC/Nga mice.嗜酸乳杆菌L-55菌株对NC/Nga小鼠特应性皮炎样皮肤损伤发展的影响。
Int Immunopharmacol. 2008 Dec 20;8(13-14):1761-6. doi: 10.1016/j.intimp.2008.08.011. Epub 2008 Oct 5.
6
Scratching behavior in spontaneous- or allergic contact-induced dermatitis in NC/Nga mice.NC/Nga小鼠自发性或过敏性接触性皮炎中的搔抓行为
Exp Dermatol. 2005 Nov;14(11):830-7. doi: 10.1111/j.1600-0625.2005.00361.x.
7
Anti-allergic effects of novel sulfated polysaccharide sacran on mouse model of 2,4-Dinitro-1-fluorobenzene-induced atopic dermatitis.新型硫酸化多糖硫酸软骨素对 2,4-二硝基-1-氟苯诱导的特应性皮炎小鼠模型的抗过敏作用。
Int J Biol Macromol. 2018 Mar;108:112-118. doi: 10.1016/j.ijbiomac.2017.11.155. Epub 2017 Nov 27.
8
Establishment of an atopic dermatitis-like skin model in a hairless mouse by repeated elicitation of contact hypersensitivity that enables to conduct functional analyses of the stratum corneum with various non-invasive biophysical instruments.通过反复激发接触性超敏反应在无毛小鼠中建立特应性皮炎样皮肤模型,该模型能够使用各种非侵入性生物物理仪器对角质层进行功能分析。
Skin Res Technol. 2004 May;10(2):122-9. doi: 10.1111/j.1600-0846.2004.00062.x.
9
A new chronic itch model accompanied by skin lesions in hairless mice.一种伴有皮肤损伤的无毛小鼠慢性瘙痒新模型。
Int Immunopharmacol. 2006 Oct;6(10):1609-15. doi: 10.1016/j.intimp.2006.06.002. Epub 2006 Jul 3.
10
Analyses of a mouse model of the dermatitis caused by 2,4,6-trinitro-1-chlorobenzene (TNCB)-repeated application.对通过反复涂抹2,4,6-三硝基-1-氯苯(TNCB)引发的皮炎小鼠模型的分析。
J Dermatol Sci. 2005 Mar;37(3):159-67. doi: 10.1016/j.jdermsci.2004.11.007. Epub 2004 Dec 31.

引用本文的文献

1
Algal polysaccharide Sacran-based conductive nanocomposites for ultrathin flexible and biodegradable organic electrochemical transistors.用于超薄柔性和可生物降解有机电化学晶体管的基于藻多糖Sacran的导电纳米复合材料。
Npj Flex Electron. 2025;9(1):56. doi: 10.1038/s41528-025-00436-1. Epub 2025 Jun 13.
2
The Cyanobacteria Genus Aphanothece: Bioactive Compounds and Applications in Biotechnology.蓝藻属微囊藻:生物活性化合物及其在生物技术中的应用。
Appl Biochem Biotechnol. 2025 Apr 3. doi: 10.1007/s12010-025-05221-4.
3
Therapeutic potential of seaweeds and their biofabricated nanoparticles in treating urolithiasis: A review.
海藻及其生物合成纳米颗粒在治疗尿石症中的治疗潜力:综述
Heliyon. 2024 Dec 11;11(1):e41132. doi: 10.1016/j.heliyon.2024.e41132. eCollection 2025 Jan 15.
4
Evaluating the Use of Sacran, a Polysaccharide Isolated from , as a Possible Microbicide for Preventing HIV-1 Infection.评估来源于 的多糖聚糖作为预防 HIV-1 感染的可能杀微生物剂的用途。
Viruses. 2024 Sep 23;16(9):1501. doi: 10.3390/v16091501.
5
Structural Analyses of Polysaccharides Extracted from Cyanobacterial Extracellular Gels and Oriented Liquid Crystalline Microfiber Processing by Poly(vinyl alcohol)-Assisted Electrospinning.从蓝藻细胞外凝胶中提取的多糖的结构分析以及通过聚乙烯醇辅助静电纺丝制备取向液晶微纤维
Gels. 2024 May 7;10(5):321. doi: 10.3390/gels10050321.
6
The Clinical Promise of Microalgae in Rheumatoid Arthritis: From Natural Compounds to Recombinant Therapeutics.微藻在类风湿关节炎中的临床前景:从天然化合物到重组治疗药物。
Mar Drugs. 2023 Dec 7;21(12):630. doi: 10.3390/md21120630.
7
Efficient pH and dissolved CO conditions for indoor and outdoor cultures of green alga .绿藻室内和室外培养的有效pH值和溶解二氧化碳条件
Front Bioeng Biotechnol. 2023 Sep 11;11:1233944. doi: 10.3389/fbioe.2023.1233944. eCollection 2023.
8
Bioprospecting for industrially relevant exopolysaccharide-producing cyanobacteria under Portuguese simulated climate.葡萄牙模拟气候下工业相关胞外多糖产生蓝藻的生物勘探。
Sci Rep. 2023 Aug 21;13(1):13561. doi: 10.1038/s41598-023-40542-6.
9
Microalgae-based wastewater treatment for developing economic and environmental sustainability: Current status and future prospects.基于微藻的废水处理以实现经济与环境可持续发展:现状与未来展望
Front Bioeng Biotechnol. 2022 Sep 7;10:904046. doi: 10.3389/fbioe.2022.904046. eCollection 2022.
10
Isolation and Investigation of Natural Rare Earth Metal Chelating Agents From - A Step Towards Unraveling the Mechanisms of Metal Biosorption.从[具体来源]中分离和研究天然稀土金属螯合剂——迈向揭示金属生物吸附机制的一步。
Front Bioeng Biotechnol. 2022 Feb 10;10:833122. doi: 10.3389/fbioe.2022.833122. eCollection 2022.